Y-mAbs Therapeutics, Inc.
USD8.61
+0.02 (+0.23%)
CEO
Michael Rossi
IPO Date
2018-09-21
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$8.61
Prev. Close
$8.59
Day Low
$8.61
Day High
$8.61
52W Low
$3.55
52W High
$16.11
Market Cap
$0.39B
Volume
0.76M
| -13.9 |
| 31 Dec 2022 | FY | 88.4% | -146.4% | -87.5% | -67.6% | 0.02 | 4.61 | -2.2 |
| 31 Dec 2021 | FY | 92.8% | -158.4% | -30.7% | -26.0% | 0.02 | 7.26 | -12.7 |
| 31 Dec 2020 | FY | 89.4% | -575.1% | -112.8% | -90.4% | 0.04 | 6.26 | -16.6 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -39.7% | -36.5% | 0.01 | 15.60 | -13.9 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -30.8% | -28.5% | 0.00 | 16.61 | -13.5 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -23.3% | -20.8% | 0.00 | 11.53 | -41.7 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -141.4% | -98.8% | 0.00 | 5.80 | -24.8 |
| -9.6 |
| 31 Dec 2024 | Q4 | 70.4% | -25.6% | -7.4% | -5.7% | 0.01 | 4.16 | -12.9 |
| 30 Sept 2024 | Q3 | 87.8% | -37.9% | -7.6% | -5.8% | 0.01 | 3.92 | -21.0 |
| 30 Jun 2024 | Q2 | 86.8% | -40.6% | -9.7% | -6.4% | 0.01 | 2.92 | -14.1 |
| 31 Mar 2024 | Q1 | 89.2% | -33.3% | -6.7% | -5.4% | 0.01 | 6.15 | -26.7 |
| 31 Dec 2023 | Q4 | 91.3% | -4.2% | -1.0% | -0.8% | 0.01 | 5.52 | -75.3 |
| 30 Sept 2023 | Q3 | 87.1% | -37.9% | -7.7% | -6.0% | 0.02 | 5.27 | -7.7 |
| 30 Jun 2023 | Q2 | 77.6% | -30.4% | -6.0% | -4.8% | 0.01 | 4.78 | -11.8 |
| 31 Mar 2023 | Q1 | 89.7% | -25.2% | -4.7% | -3.7% | 0.01 | 4.78 | -10.7 |